SIG
IONS icon

Senator Investment Group’s Ionis Pharmaceuticals IONS Stock Holding History

Senator Investment Group’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-135,000
Closed -$5.85M – 78
2024
Q1 		$5.85M Hold
135,000
– – 0.27% 57
2023
Q4 		$6.83M Buy
+135,000
New +$6.47M 0.29% 58

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
TBC
Tweedy, Browne Co Stamford, Connecticut $1.26B AUM 33.88% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Senator Investment Group's IONS Position: Q2 2024 in Review

Senator Investment Group sold out of Ionis Pharmaceuticals (IONS) in Q2 2024, closing a stake of 135,000 shares — an estimated $5.85M sold.

Senator Investment Group first reported a position in IONS in Q4 2023 and held it in 2 quarters. The position peaked at $6.83M in Q4 2023. 356 funds tracked by Wall St. Rank hold IONS as of Q2 2024.

  • Senator Investment Group reported no remaining Ionis Pharmaceuticals position as of Q2 2024 after selling out during the quarter.
  • Senator Investment Group sold 135,000 Ionis Pharmaceuticals shares in Q2 2024, an estimated $5.85M.
  • Senator Investment Group first reported a position in Ionis Pharmaceuticals in Q4 2023 and held it in 2 quarters.
  • Senator Investment Group's Ionis Pharmaceuticals position peaked at $6.83M in Q4 2023.
  • 356 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2024.

Based on Senator Investment Group's 13F filing for Q2 2024, filed 20 Aug 2024.